#COVID19 $PFE $BNTX Pfizer and BioNTech announced that the first participants have been dosed in the U.S. in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19.

First participants dosed at NYU and University of Maryland.

https://t.co/X7ENjea4PT